Tadalafil recalls
Tadalafil products have been recalled 9 times, most recently on 3 May 2023. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls9since 2021
Last 12 months0reported
Class I00% of total
Ongoing3latest 3 May 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 9 100%Class III 0 0%
Why tadalafil is recalled
Companies
By year
Ongoing tadalafil recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tadalafil Tablets, USP 5 mg recalled by Northwind PharmaceuticalsTadalafil | Northwind Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Tadalafil Tablets, USP 20 mg recalled by Northwind PharmaceuticalsTadalafil | Northwind Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Tadalafil Tablets, USP, 20 mg recalled by Preferred PharmaceuticalsTadalafil | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
All tadalafil recalls, newest first
9 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.